Reuters logo
BRIEF-Regeneron Pharmaceuticals ‍announces new collaborations with HHS to develop antibodies against ebola, influenza, multiple other emerging pathogens​
October 2, 2017 / 11:31 AM / 19 days ago

BRIEF-Regeneron Pharmaceuticals ‍announces new collaborations with HHS to develop antibodies against ebola, influenza, multiple other emerging pathogens​

Oct 2 (Reuters) - Regeneron Pharmaceuticals Inc:

* Regeneron Pharmaceuticals Inc - ‍announces new collaborations with hhs to develop antibodies against ebola, influenza, multiple other emerging pathogens​

* Regeneron Pharmaceuticals - ‍first selected program will receive initial funding of more than $18 million for early-stage antibody discovery, development and manufacturing

* Regeneron Pharmaceuticals - ‍under separate ebola agreement, hhs will provide about $40 million in initial committed funding for continued development of regn3470-3471-3479​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below